Bayer Sells Its Animal Health Business For $7.6 Billion Amid Mounting Roundup Cancer Claims

  • 📰 Forbes
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 53%

United States News News

United States United States Latest News,United States United States Headlines

Bayer's sale of its animal health business comes after the German chemicals giant proposed an $8 billion payout to settle all cases alleging that Monsanto's Roundup weed killer causes cancer.

: Bayer will sell its animal health business to Elanco for $7.6 billion as the German chemical and pharmaceutical giant tries to reorganize its business following its acquisition of Monsanto, which faces scores of lawsuits over claims its pesticide Roundup causes cancer.after regulatory approval and other conditions, will create the second-largest animal health company after Zoetis, with a 13% market share.

Bayer will receive $5.3 billion in cash and a $2.3 billion stake in the American pharmaceuticals firm, which it will sell over time.that it would shed its animal health division as part of a bigger cost-saving drive and so that it could focus on its agriculture and drug divisions. The business, based in Leverkusen, Germany, has already raised $550 million with the sale of the Coppertone sun protection business in May, and $585 million from its Dr Scholl’s unit in July.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Bayer=Monsanto. Wake up folks. They are killing us and your pets.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in US

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Elanco buying Bayer's animal health business for $7.6 billionElanco Animal Health said it's buying Bayer's animal health business for $7.6 billion. Elanco said it will pay $5.32 billion in cash and $2.28 billion in...
Source: MarketWatch - 🏆 3. / 97 Read more »

With General Atlantic Investment, Morphe Plans to Buy More Brands.MorpheBrushes has more than a $2.2 billion valuation and is planning to buy more brands.
Source: wwd - 🏆 24. / 68 Read more »